1. Home
  2. SUPN vs GPK Comparison

SUPN vs GPK Comparison

Compare SUPN & GPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.86

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

HOLD

Current Price

$9.56

Market Cap

2.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
GPK
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
SUPN
GPK
Price
$47.86
$9.56
Analyst Decision
Strong Buy
Hold
Analyst Count
5
9
Target Price
$61.60
$13.08
AVG Volume (30 Days)
642.1K
7.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
4.58%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
$8,617,000,000.00
Revenue This Year
$22.70
N/A
Revenue Next Year
$19.14
$1.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.16
$8.79
52 Week High
$59.68
$23.76

Technical Indicators

Market Signals
Indicator
SUPN
GPK
Relative Strength Index (RSI) 41.06 44.12
Support Level $47.73 $8.98
Resistance Level $52.36 $10.02
Average True Range (ATR) 2.17 0.49
MACD -0.16 -0.06
Stochastic Oscillator 16.25 10.32

Price Performance

Historical Comparison
SUPN
GPK

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

Share on Social Networks: